Abstract: Polycystic ovary syndrome (PCOS) is a complex endocrine condition characterized by polycystic ovarian morphology (PCOM), oligo-or anovulation, and clinical or biochemical hyperandrogenism. Intracytoplamic sperm injection (ICSI) has been used extensively in treatment of infertile women with PCOS. In Iraq, pregnancy outcomes in PCOS patients following ICSI have yet to be evaluated. This study has therefore been conducted to define pregnancy outcomes in Iraqi PCOS patients as well as to define oocyte meiotic competence and normality following ovarian hyperstimulation. Although high doses of gonadotropin were used in infertile women with normal ovaries, the numbers of retrieved oocytes and estradiol peak levels were higher in patients with PCOM and PCOS than in patients with normal ovaries(P≤0.01). Wealso found that PCOM women have higher antral follicle count (AFC) than did PCOS women(P=0.0001). Moreover, significant high mean numbers of immature, mature, and degenerated oocytes were observed in PCOS and PCOM patients in comparison to those in control patient, which might be due to the high bulk of AFC and consequently higher numbers of oocyte recovered in PCOS or PCOM. As for ICSI outcomes, PCOS or PCOM patients had significantly higher fertilization, grade one embryo, embryo transfer and implantation, pregnancy, and live birth rates than did control patients. It is concluded that infertile women with PCOS or PCOM have higher pregnancy rates than do infertile women with unexplained or tubal-type infertility following ICSI.
Introduction
Polycystic ovary syndrome (PCOS) is recognized as one of the most common endocrine/metabolic disorders of women. Its prevalence depends in part upon the diagnostic criteria used to define the disorder. The prevalence of PCOS under National Institutes of Health (NIH), Rotterdam, and Androgen Excess and PCOS Society criteria was 6.1, 19.9 and 15.3%, respectively [1] . The Rotterdam criteria state that two out of the following three criteria should be present in the diagnosis of PCOS: oligo-anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovaries of 12 or more follicles measuring 2-9 mm in diameter in the whole ovary and/or increased ovarian volume (>10 cm 3 ).Although polycystic ovary morphology and PCOS overlap, and PCOM is included in the definition of PCOS, diagnosis of patients with PCOM depends only on observing 12 or more follicles measuring 2-9 mm in diameter in the whole ovary and/or increased ovarian volume (>10 cm 3 ) according to the Rotterdam criteria [2] .
In Iran, 12 studies were designed to evaluate the prevalence rate of infertility, and a meta-analysis was performed to integrate the findings of these separate studies. The average rate of infertility was 10.9% [3] . According to another study conducted by the Egyptian Fertility Care Society, and sponsored by the World Health Organization (WHO), infertility in Egypt affects 12 percent of couples. Of these women, 4.3 percent suffer from primary infertility and 7.7 percent suffer from secondary infertility [4] . In a cohort study from Duhok, Iraq, from January 2000 to May 2001, the causes of infertility were studied for 250 couples. The investigators found that 77.2% of infertile couples had primary infertility and 22.8% had secondary infertility. Male infertility was found in 36.8% of the cases [5] . Only few studies were done to estimate the prevalence of PCOS in the Middle East. Two large Iranian studies found the prevalence of PCOS to be around 7% [6] [7] .To the best of our knowledge, pregnancy outcomes in infertile women with PCOS following assisted reproductive technology have yet to be studied.
Intracytoplasmic sperm injection (ICSI) has become the mainstay in the treatment of PCOS. The ability of ICSI to achieve fertilization regardless of sperm quality has made this technique an ideal procedure to treat severe male factor infertility as well as PCOS. In Iraq, most of PCOS women are treated with ICSI. Moreover, oocyte maturation and normality in polycystic ovarian patients are not fully defined. This study was therefore designed to define the pregnancy outcomes, including oocyte maturation and degeneration rate, in infertile women with PCOM or PCOS undergoing hyperstimulation and ICSI. 
Ultrasonography and PCOS diagnosis
For ultrasound screening, a transvaginal ultrasonographic screening with 6.5 MHz vaginal transducer (GE LOGIQ P3 Expert/Logic P3, probe destination E8CS/E8C, USA) was used. According to Rotterdam-PCOS criteria, patients with PCOS were diagnosed if at least two of the following criteria were observed: oligomenorrhoea/anovulation, defined by a delayed menses (>35 days) or less than eight spontaneous hemorrhagic episodes/year; clinical hyperandrogenism, defined by hirsutism using modified Ferriman-Gallwey score of ≥8 or biochemical hyperandrogenism of total testosterone > 0.481 ng/ml; and/or PCOM on ultrasonography of more than 12 follicles of 2-9 mm per ovary.
In addition, women without oligomenorrhea/amenorrhea and hyperandrogenism but with 12 or more follicles/ovary, measuring 2-9 mm in diameter, were diagnosed with PCOM [8] [9] .The transvaginal ultrasonic screening was performed during the follicular phase, second or third day of the cycle.
Ovarian hyperstimulation and ICSI
The ovarian stimulation was started 2-3 cycles after the patient`s first visit to the center. Patients were started with 75-300 IU of gonadotropin based on age, body mass index (BMI), basal FSH, and patient response. Ovarian response was monitored with serum E 2 measurement and transvaginal ultrasonography startingon day six of the cycle. A single intramuscular injection of highly purified hCG of 10000IU (hCG;
Choriomon®, IBSA-InstitudBiochimique, Switzerland) was administered to patients when at least 2-3 follicles became more than 17-18 mm in diameter. Transvaginal oocyte retrieval was conducted 34-36hr after the hCG administration. Oocytes were first washed in GMops plus medium (Vitrolife, Sweden) and incubated in G-IVF Plus medium supplemented with human serum albumin (Vitrolife, Sweden) at 37°C and 6% CO 2 in humidified air for 2hr. Oocytes were then denuded and evaluated for meiotic maturation and morphology. Briefly, oocytes that showed a nuclear membrane and intact nucleolus were classified as meiotically immature oocytes at the germinal vesicle stage (GV). Oocytes that had undergone GV breakdown, but did not have a polar body, were classified as metaphase I (MI) oocytes, whereas those with first polar bodies were classified as metaphase II (MII) oocytes [10] . As for oocyte morphological normality, oocytes with smooth granular or transparent cytoplasm, single polar body, appropriate zona pellucida thickness, and proper perivitelline space (PVS) were considered normal and consequently used in ICSI. Conversely, oocyteswith coarse granular, non-homogeneous, dark (brownish-blackish), or fragmented cytoplasm; distorted oolemma;or non-spherical (irregular shape) with or without large PVS were considered degenerated [10] [11] [12] [13] .
Semen was collected by masturbation after an abstinence period of three days. Thirty to forty minutes were allowed for semen to liquefy at 37ºC before seminal analysis according to World Health Organization criteria [14] .On day of insemination, Sperm preparation was carried out using the swim-up method.In cases of severe poor semen parameters, spermatozoa were prepared by mixing equal volumes of GMOPS+ medium and semen, centrifuging twice, and resuspending the pellet in small volume of media before injection. Inseminated oocytes were washed and incubated in groups of 3 oocytes in 40µl G1+ medium droplet (Vitrolife, 101128, Sweden) covered with mineral oil. The oocytes were then cultured for 18-20h before evaluation for fertilization under a high power inverted microscope. Fertilization was considered normal when two clearly distinct pronuclei were observed plus the 2 nd polar body. If a single pronucleus was observed, a second evaluation was carried out after an addition 4hr [15] . Embryos were cultured at 37ºC and 6% CO 2 in humidified air before transferred on day three after fertilization. On average 3-4 embryos of high gradeswere selected and transferred using G2+ media (vitrolife, Sweden) and embryo transfer catheters (Cook,K-JETS-7019-SIVF,Austrila).
Luteal phase support
Women were treated orally with 10mg tablet of synthetic progesterone (dydrogesterone, duphaston ® , Abbott, USA), tid, and 400mg pessaries of natural progesterone (cyclogest ® , Actavis, UK) once a day. Both luteal support therapies were started one day after the oocyte retrieval and continued for two weeks. If the β-hCG assay showed a positive result after two weeks from the transfer, both medications were continued for an additional 12-16 weeks.
Biochemical and clinical pregnancy and ICSI outcomes
Patients were considered to have positive biochemical pregnancy when β-hCG was >20 IU/l. The test was repeated 2 days later to confirm the results.Patients were considered to have clinical pregnancies when a gestation sac and a viable fetal heart beat were observed five weeks from the transfer. Early pregnancy loss or miscarriage was defined as the loss of a pregnancy before 20 weeks.
Results
Clinical data of control, PCOM, PCOS patients following ovarian hyperstimulation All control, PCOM, or PCOS patients underwent ovarian hyperstimulation with a starting dose of 75-300 IU of gonadotropin. Patients with PCOS or PCOM required less number of gonadotropin doses, as defined by the total number of vials used, than did control patients, 25 
Discussion
This study demonstrates that although high doses of gonadotropin were used in infertile women with normal ovaries, the numbers of retrieved oocytes and E2 peak levels were higher in patients with PCOM and PCOS more than in patients with normal ovaries. This might be due to the fact that patients with PCOS or PCOM have high antral follicle count (AFC), and by inclusion criteria, patients with AFC >12 follicles/ovary were classified as PCOM or PCOS patients. Interestingly, basal follicle number had a positive linear correlation with recovered oocytes and basal and peak E2 and a negative linear correlation with both number of ampules of administered gonadotropin and days of stimulation [16] [17] [18] . This means in patients with normal ovaries, a set of follicles, from a follicular pool of less than 12 follicles/ovary, will develop and ovulate during the ovarian hyperstimulation. However, in patients with PCOS or PCOM, more follicles will have the chance to develop and ovulate. This aids to explain why less numbers of oocytes were recovered in control patients despite of high doses of gonadotropin administered. An additional reason, clinicians usually administer gonadotropins in PCOS/PCOM patients with precaution, because thosepatients are sensitive for exogenous gonadotropins and may easily develop ovarian hyperstimulation syndrome [19] . This can create a non-favorable bias regarding the number of administered gonadotropin doses in PCOS or PCOM patients. Moreover, the stimulation periods of time were similar in all patient groups. From experience, this might me due to the fact that follicular response in PCOS and PCOM patients tends to be slow but explosive at later stages.
It has been agreed that women with AFC greater than 12 follicles (measuring 2-9 mm in diameter) are considered to have polycystic ovaries. In this study, we found that PCOM women have higher AFC than PCOS women. This might due to the fact that PCOM women are solely classified depending on the AFC, i.e patients with greater than 12 follicles. However, it is not necessary that all PCOS patients have AFC greater than 12 follicles, because there are four phenotypes of PCOS where they may have or not have AFC greater than 12 follicles. In other words, not all of phenotypes of PCOS are diagnosed based on the presence of high AFC. hyperandroginisim and does not include AFC [2] . Therefore, in our study although all PCOM patients (100%) had high AFC, only 82.6% of our PCOS patients had high AFC. This may explain the high levels of AFC in PCOM patients over PCOS patients.
We observed high mean numbers of immature and mature oocytes in PCOS and PCOM patients in comparison to those in control patient. Although the increase in mean number of mature oocytes in PCO patients would be expected as those patients ovulated more oocytes due to their high bulk of AFC, the recovery of immature and degenerated oocytes is questionable. Patients with PCOS or PCOM have ovarian hyperandrogenism and hyperinsulinemia. As for hyperandrogeism, hyperanodgenic oocytes were observed to associate with abnormal gene expression profiles that involve signal transduction, transcription, chromosome alignment, and segregation during mitosis andmeiosis [20] . Moreover, cumulus cells from women with PCOS were characterized by abnormal expression of many growth factors that are known to play a role in oocyte maturation and developmental competence [21] [22] .In addition, a dosedependent inhibition of meiotic maturation was observed in both cumulus-enclosed and cumulus-denuded murine oocytes following incubation with testosterone for 18h [23] . In addition to hyperandrogenism, and as stated earlier, recovery of immature and degenerated oocytes in PCOS patients could also be due to hyperinsulinemia. Insulin sensitivity in PCOS patients is intrinsically impaired with abnormal post-receptor signal transduction; thereby, resulting in reduced insulin-mediated glucose uptake in oocytes and impaired glucose-insulin homeostasis in oocytes [24] [25] . This impairment in insulin sensitivity and hyperinsulinemia in PCOS patients enhance also androgen productionleading to arrest of cell proliferation and follicle growth [26] [27] . These data clearly explain that ovarian hyperandrogenism, recognized in PCO patients, contributes to oocyte incompetence and atresia.
Studies regarding the impact of PCOS or PCOM on oocyte competence are conflicting [28] [29] [30] [31] [32] [33] . Many factors could have been responsible on this contradiction such as ovulation induction program, patient age and ethnicity [34] , and BMI. The present study shows high pregnancy rates in patients with PCOS or PCOM. Hperinsulinemia, heperandrogenism, metabolic syndrome have contributed to arrest several growing follicles at the small antral stage but unlikely to compromise further follicular growth and oocyte meiotic maturation after the initiation of ovarian hyperstimulation. We also report that patients with PCOS or PCOM had favorable ICSI outcomes; fertilization, grade one embryo, embryo transfer and implantation, pregnancy, and live birth rates, which might be due to greater numbers of follicles available and consequently oocytes retrieved in PCOS and PCOM patients than in control patients with tubal infertility factor. In addition, PCOS and PCOM patients received low doses of gonadotropin in comparison to control patients. Exogenous administration of gonadotropin has been observed to negatively impact embryo quality [35] . The utilization of low doses of gonadotropin plus the recovery of great numbers of MII oocytes might have reduced the impact of high incidence of degeneratedand immature oocytesrateson pregnancy outcomes in PCOS and PCOM patients. Moreover, the lack of association between PCOS and embryonic aneuploidy [36] , and the similar chromosomal normality of unfertilized oocytes from patients with or without PCSO [37] , might have also contributed to the high pregnancy outcomes in PCSO or PCOM patients observed in this study.
In conclusion, this study is in agreement with other reports indicating high pregnancy rates in PCOS patients following assisted reproductive technology [38] [39] [40] [41] . Moreover, oocyte meiotic maturation and degeneration rates in Iraqi patients with PCOS or PCOM were also evaluated.
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